
NOVEL is an innovative biotechnology company that combines knowledge in molecular biology with data analysis technologies. Founded in 2004 in Novosibirsk, it has offices in multiple locations including the USA and China. The company employs over 50 highly qualified developers and specialists in data science, machine learning, bioinformatics, and biology, with a mission to support the development of biotechnology companies and scientific organizations. NOVEL offers services to pharmaceutical companies, software developers, scientific laboratories, diagnostic centers, and biobanks, focusing on complex data processing and software system development. The company is positioned at the forefront of the growing market for AI, machine learning, and molecular-genetic technologies, aiming to be a leader in this new technological landscape.

NOVEL is an innovative biotechnology company that combines knowledge in molecular biology with data analysis technologies. Founded in 2004 in Novosibirsk, it has offices in multiple locations including the USA and China. The company employs over 50 highly qualified developers and specialists in data science, machine learning, bioinformatics, and biology, with a mission to support the development of biotechnology companies and scientific organizations. NOVEL offers services to pharmaceutical companies, software developers, scientific laboratories, diagnostic centers, and biobanks, focusing on complex data processing and software system development. The company is positioned at the forefront of the growing market for AI, machine learning, and molecular-genetic technologies, aiming to be a leader in this new technological landscape.